Vibrant99 Solutions

🎉🎂 Belated Happy Birthday to our incredible Co-Founder! Daniel Hendrickson 🌟🎈 Although we're a bit late, our best wishes for your future goals and endeavors are as strong as ever. Your vision and dedication inspire us all to reach for greatness every day. Here’s to many more successes and milestones ahead! 🚀💪 Keep shining and leading us forward! Vibrant99 Solutions #BelatedBirthday #CoFounder #Inspiration #FutureGoals #TeamSpirit #OnwardAndUpward #Vibrant99 #BestWishes #LinkedIn

Epic Systems is building over 100 new AI features for doctors and patients. Here’s what’s coming Epic Systems is a healthcare software company whose technology is used in thousands of hospitals and clinics across the country. Thousands of industry leaders are visiting Epic’s headquarters in Verona, Wisconsin this week to learn about its new products and updates. Many of Epic’s announcements centered around AI, which the company is working to integrate into its offerings like MyChart and Cosmos. Vibrant99 Solutions EPIC Systems CNBC #Vibrant99 #EPICSystems #CNBC #IT #AI #Doctors #New #Updates #Latest #Article #LinkedIn

FDA Lifts Partial Hold on BioNTech, MediLink’s ADC Cancer Trial In June, the regulator placed a partial clinical hold on a Phase I trial of the companies’ antibody-drug conjugate after three patient deaths were reported. Vibrant99 Solutions FDA Biontech Medilink International BioSpace #News #Article #Latest #Pharma #FDA #Vibrant99 #BioNtech #Medilink

The Vibrant99 Solutions USA Team is thrilled to join in celebrating India’s Independence Day alongside our wonderful colleagues in India! 🇺🇸🇮🇳 💟🫡 Let’s come together to honor this significant occasion with joy and unity, and strengthen our global bond of friendship and collaboration. Here’s to celebrating our shared values and diverse cultures! 🎉🌟🤝🎆🇮🇳 #IndependenceDay #GlobalTeam #CelebratingTogether #USAandIndia

Ascendis’ Hypoparathyrodism Drug Secures FDA Approval Following Tough Regulatory Path Ascendis Pharma's palopegteriparatide was earlier turned down by the regulator because of manufacturing issues, and the review period for its resubmitted application has been extended by three months. Vibrant99 Solutions Ascendis Pharma BioSpace #Vibrant99 #Ascendis #Pharma #Biospace #Bio #Tech #Information #Updates #News #Latest #Article #LinkedIn

Cell and Gene Therapy Shows Early Promise Against Alzheimer’s—But Challenges Remain Longeveron and Lexeo Therapeutics are working on CGT therapies to treat Alzheimer’s disease, but it’s not clear whether they have a better chance of success than traditional approaches. Click the below link to read the full article. Vibrant99 Solutions Longeveron Inc Lexeo Therapeutics BioSpace #Vibrant99 #Longeveron #lexeo #Bio #Pharma #News #Latest #Updates #Article #LinkedIn

Microsoft’s cloud is ‘no-brainer’ for some AI startups, helping Azure gain ground on AWS Microsoft is enticing Y Combinator startups with more cloud credits that can be used to access technology needed to run artificial intelligence workloads. A Microsoft spokesperson said 58% of Y Combinator startups had accepted the company’s offer of Azure credits. Click the below link to give it a full read. Vibrant99 Solutions Microsoft CNBC #Vibrant99 #Microsoft #CNBC #Tech #Technology #IT #News #Updates #AI #Latest #Article #Linkedin

Zevra Gains Support of Adcomm, Clears Hurdle for Potential Rare Disease Approval An FDA advisory committee agreed on Friday that Zevra Therapeutics had provided sufficient efficacy data supporting the approval of arimoclomol for Niemann-Pick disease type C. Click the below link to give it a full read. Vibrant99 Solutions Zevra Therapeutics BioSpace #Vibrant99 #Zevra #Pharma #Bio #Tech #BioTech #Updates #News #Latest #Article #LinkedIn

Lilly’s Tirzepatide Clears Phase III Cardiovascular Study on Heels of Novo Eli Lilly on Thursday released late-stage data showing a 38% reduction in the risk of heart failure outcomes, as it plays catch-up with Novo Nordisk’s semaglutide which won the FDA’s cardio nod in March. Vibrant99 Solutions Eli Lilly and Company BioSpace #Pharma #Bio #BioTech #News #Article #Updates #New #Latest #Vibrant99 #Lilly #BioSpace

Generative AI requires massive amounts of power and water, and the aging U.S. grid can’t handle the load Thanks to the artificial intelligence boom, new data centers are springing up as quickly as companies can build them. This has translated into a huge demand for power to run and cool the servers inside. Click the below link to give it a full read. Vibrant99 Solutions CNBC Generative AI #AI #Tech #Knowledge #Data #Technology #Vibrant99 #CNBC #GenerativeAI #LinkedIn #Article